Lindsey, JW
24  Ergebnisse:
Personensuche X
?
1

P.010 Safety and efficacy of inebilizumab in AQP4+ NMOSD pa..:

Paul, F ; Marignier, R ; Lindsey, JW...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  51 (2024)  s1 - p. S17-S17 , 2024
 
?
2

P.009 Long-term comparative efficacy of inebilizumab from N..:

Cree, B ; Suero, B ; Walsh, S...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  51 (2024)  s1 - p. S16-S17 , 2024
 
?
4

Sudden unexpected death on fingolimod:

Lindsey, JW ; Haden-Pinneri, K ; Memon, NB.
Multiple Sclerosis Journal.  18 (2012)  10 - p. 1507-1508 , 2012
 
?
5

Continuous long-term immunomodulatory therapy in relapsing ..:

Ford, C. ; Goodman, AD ; Johnson, K....
Multiple Sclerosis Journal.  16 (2010)  3 - p. 342-350 , 2010
 
?
 
?
7

Review: PCR for bacterial 16S ribosomal DNA in multiple scl..:

Lindsey, JW ; Patel, S.
Multiple Sclerosis Journal.  14 (2007)  2 - p. 147-152 , 2007
 
?
8

T cell-T cell activation in multiple sclerosis:

Lindsey, JW ; Kerman, RH ; Wolinsky, JS
Multiple Sclerosis Journal.  3 (1997)  4 - p. 238-242 , 1997
 
?
 
?
11

Continuous long-term immunomodulatory therapy in relapsing ..:

Ford, C ; Goodman, AD ; Johnson, K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850588.  , 2010
 
?
12

Abacavir Pharmacokinetics During Chronic Therapy in HIV-1-I..:

Sleasman, JW ; Robbins, BL ; Cross, SJ...
Clinical Pharmacology & Therapeutics.  85 (2008)  4 - p. 394-401 , 2008
 
1-15